Literature DB >> 2136584

Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis.

J Miró1, J L Peña-Sagredo, J Berciano, S Insúa, C Leno, R Velarde.   

Abstract

Sixty-four consecutive patients with clinically or laboratory-supported definite multiple sclerosis (MS) were evaluated prospectively for evidence of primary Sjögren's syndrome (SS). This diagnosis was established when a patient had objective keratoconjunctivitis sicca, xerostomia, or both together with positive labial salivary gland biopsy. We found 2 patients (3.1%) with clinical evidence of primary SS. Whether this association is fortuitous or whether there is pathogenetic linkage between MS and primary SS remains to be established.

Entities:  

Mesh:

Year:  1990        PMID: 2136584     DOI: 10.1002/ana.410270522

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

1.  Central nervous system involvement in Sjogren's syndrome.

Authors:  F C Soliotis; C P Mavragani; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

2.  Conjunctival impression cytology and tear film parameters in patients with multiple sclerosis.

Authors:  Selman Belviranli; Pembe Oltulu; Ali Ulvi Uca; Ali Osman Gundogan; Enver Mirza; Mustafa Altas; Nazli Turk; Refik Oltulu
Journal:  Int Ophthalmol       Date:  2021-10-01       Impact factor: 2.031

3.  Neurological manifestations of connective tissue diseases mimicking multiple sclerosis.

Authors:  Sigliti-Henrietta Pelidou; Sotiris Giannopoulos; Sotiria Tzavidi; Niki Tsifetaki; Georgios Kitsos; Dimitrios Stefanou; Vassiliki Kostadima; Alexandros A Drosos; Athanassios P Kyritsis
Journal:  Rheumatol Int       Date:  2007-06-15       Impact factor: 2.631

4.  Astasia-abasia revealing a primary Sjögren's syndrome.

Authors:  P Lafforgue; E Toussirot; F Billé; P C Acquaviva
Journal:  Clin Rheumatol       Date:  1993-06       Impact factor: 2.980

5.  Neurological Complications of Sjögren's Syndrome: Diagnosis and Management.

Authors:  Sara S McCoy; Alan N Baer
Journal:  Curr Treatm Opt Rheumatol       Date:  2017-10-24

Review 6.  A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.

Authors:  Ruth Ann Marrie; Nadia Reider; Jeffrey Cohen; Olaf Stuve; Per S Sorensen; Gary Cutter; Stephen C Reingold; Maria Trojano
Journal:  Mult Scler       Date:  2014-12-22       Impact factor: 6.312

Review 7.  A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview.

Authors:  Ruth Ann Marrie; Jeffrey Cohen; Olaf Stuve; Maria Trojano; Per Soelberg Sørensen; Stephen Reingold; Gary Cutter; Nadia Reider
Journal:  Mult Scler       Date:  2015-01-26       Impact factor: 6.312

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.